Status
Conditions
Treatments
About
The purpose of this clinical trial is to evaluate the effectiveness and safety of this spinal robot in assisting doctors to perform laminectomy in spinal surgery under the premise of ensuring the safety of the subjects and ensuring the scientific nature of the clinical trial.
Full description
This is a multicenter, randomized, blind evaluation, parallel-controlled, and superiority clinical trial. The objective of this study is to evaluate the effectiveness and safety of a spinal robot in assisting surgeons in laminectomy. The experiment included 3 centers with a total sample size of 70. The experimental group is the robot laminectomy group (RL group), and the control group is the manual laminectomy group (ML group). Laminectomy in the RL group is performed robotically, while laminectomy in the ML group is performed by the physician using an ultrasonic osteotome. The primary outcome measure is the accuracy of laminectomy. Secondary outcome measures included JOA score, VAS score, laminectomy success rate, laminectomy time per spinal segment, total laminectomy time, operative time, amount of surgical bleeding, number of X-ray exposures and total dose, and planned area excision rate. The evaluation was completed by comparing the outcomes between the two groups.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients aged 18-80 years old (including 18 and 80 years old), regardless of gender;
Patients with complete clinical data, willing and able to sign informed consent;
Patients with lumbar disc herniation, lumbar spinal stenosis, lumbar instability, lumbar spondylolisthesis, and lumbar fracture meet the indications for spinal laminectomy and undergoing open surgery;
Patients with lumbar disc herniation, lumbar spinal stenosis, or lumbar instability have one of the following:
Lumbar spondylolisthesis occurs in one of the following:
The TLISS score of lumbar spine fracture is greater than or equal to 4 points.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
70 participants in 2 patient groups
Loading...
Central trial contact
Zhuofu Li, M.D.; Weishi Li, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal